Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Four-times-daily versus twice-daily mycophenolate mofetil dosing for diarrhea in renal transplant patients
NL-OMON30619Phase 4Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mycophenolate mofetil in kidney transplant immunosuppression (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Stool frequency, Feces weight and 1 more. Started May 2008; status: active, not recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney transplant immunosuppression
Beyond the preview
Go deeper on NL-OMON30619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30619.